C12N 2770/32321
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2770/32321 (Viruses as such) appears on 19 US grants and 35 published applications in this corpus.
Search patents in C12N- Granted patents
- 19
- Published applications
- 35
- Assignees
- 29
- Inventors
- 124
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 2 |
| 2017 | 1 | 0 |
| 2018 | 1 | 2 |
| 2019 | 2 | 3 |
| 2020 | 2 | 6 |
| 2021 | 0 | 3 |
| 2022 | 2 | 5 |
| 2023 | 3 | 2 |
| 2024 | 1 | 2 |
| 2025 | 4 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Optimized oncolytic viruses and uses thereof13 Jan 2026US 12,521,424 B2Sator Therapeutics
- Antitumor virus30 Dec 2025US 12,508,291 B2Shanxi Academy of Advanced Research and Innovation
- Optimized oncolytic viruses and uses thereof15 Jul 2025US 12,357,664 B2Sator Therapeutics
- Adapted enterovirus D68 that propagates to high titer in vero cells6 May 2025US 12,290,555 B2Bharat Biotech International Limited
- Coxsackievirus A6 strain CVA6-KM-J33 and use thereof4 Feb 2025US 12,215,358 B1Institute of Medical Biology, Cams
- Compositions and methods for improved protein translation from recombinant circular rnas13 Aug 2026US 2026/0234654 A1The Board of Trustees of the Leland Stanford Junior University
- Genetically modified enterovirus vectors with enhanced genomic stability2 Oct 2025US 2025/0304999 A1Virogin Biotech Canada Ltd
- Using infectious nucleic acid to treat cancer7 Aug 2025US 2025/0249053 A1Mayo Foundation for Medical Education and Research
- Coxsackievirus 83 Vaccine8 Aug 2024US 2024/0261386 A1King Faisal University
- Encapsulated rna polynucleotides and methods of use11 Apr 2024US 2024/0115636 A1ElevateBio Technologies, Inc.
Most cited
By later US patents
- Viruses associated with immunodeficiency and enteropathy and methods using same9US 9,683,268 B2Beth Israel Deaconess · 2017
- Gene-modified coxsackievirus1US 10,076,547 B2Kyushu University, National University Corporation · 2018
- Methods and compositions for treatment of hematologic cancers1US 8,236,298 B2Viralytics Limited · 2012